Quantcast
Last updated on April 24, 2014 at 1:21 EDT

Latest Retinoids Stories

2009-06-26 15:32:00

TRENTON, N.J., June 26 /PRNewswire/ -- Marcus Rayner, executive director of the New Jersey Lawsuit Reform Alliance, a statewide, bipartisan group of individuals, businesses and organizations dedicated to improving the state's civil justice system and advocating for legal reform in the legislature and in the courts, today issued the following statement in reaction to Roche's announcement that the company will immediately discontinue Accutane(R), a treatment for severe acne: "Thanks to an...

2fd3bb543c6dd19dde6f054b1ddcbd4c1
2009-06-26 14:28:34

Roche Holding AG announced on Friday that it is no longer selling its acne drug Accutane amid slowing sales due to the move towards generic alternatives. "As always when you have generics around your market share drops," Roche spokeswoman Martina Rupp told Reuters. "This was an economical decision driven by falling market share," she said. Indeed, Accutane's market share had declined to around 4 to 5 percent. Generics of the potent drug have been available since 2002 and now dominate the...

2009-03-17 11:43:00

Company brings the latest in Italian skin care to the U.S. TURIN, Italy, March 17 /PRNewswire/ -- Direct from Italy, Perlabella PureDose Pearls bring the latest in anti-aging skin care technology to America. The skin care line offers four highly concentrated anti-aging serums: Retinol Face, Q10 Face, Vitamin C Face and Retinol Eye. "Perlabella PureDose Pearls are unique because they are airtight, making it impossible for water, air or preservatives to compromise the integrity of their...

2009-03-06 17:59:00

SAN DIEGO, March 6 /PRNewswire/ -- AndroScience Corporation (ASC(TM)), a developmental stage pharmaceutical company announced results of a Phase 2a dose-ranging study of their lead clinical compound for the treatment of acne. The randomized, double-blinded, vehicle-controlled study completed in late 2008 enrolled 186 patients with acne and consisted of twice daily topical applications of ASC-J9(TM) cream for 12 weeks to evaluate safety and ascertain preliminary efficacy. ASC-J9(TM)...

2009-03-06 09:00:00

Expanded Dermatology Division of Valeant Pharmaceuticals Introduces Fixed Combination Acne Treatment Designed to Increase Patient Satisfaction and Use SAN FRANCISCO, March 6 /PRNewswire-FirstCall/ -- Coria Laboratories, the newly expanded dermatology division of Valeant Pharmaceuticals International (NYSE: VRX), announced today the commercial launch of Acanya(TM) Gel (clindamycin phosphate 1.2% and benzoyl peroxide 2.5%) indicated for the once-daily treatment of acne vulgaris in patients 12...

2009-02-26 07:00:00

FORT WORTH, Texas, Feb. 26 /PRNewswire-FirstCall/ -- Coria Laboratories, the newly expanded dermatology division of Valeant Pharmaceuticals International (NYSE: VRX), today announced six data presentations on Acanya Gel at the 67th Annual Meeting of the American Academy of Dermatology (AAD), taking place March 6 - 10, 2009, at the Moscone Center, San Francisco. The presentations demonstrate the efficacy and safety of once daily Acanya Gel (clindamycin phosphate 1.2% and benzoyl peroxide...

2009-01-20 22:34:13

Patient deaths that led to a clinical trial being halted early may have had nothing to do with the anti-cancer cream being tested, U.S. researchers say. The trial was testing a cream containing tretinoin, a retinoid commonly used to treat acne and other conditions, to prevent skin cancer. A total of 1,131 veterans -- 97 percent male -- with an average age of 71 years were randomly assigned to apply either a cream containing 0.1 percent tretinoin or an unmedicated cream daily to their face...

2009-01-20 09:36:47

Patients using a cream containing tretinoin, a retinoid commonly used to treat acne and other conditions, appeared more likely to die than those using a placebo in a clinical trial that was halted early as a result, according to a report in the January issue of Archives of Dermatology, one of the JAMA/Archives journals. However, evidence does not suggest these excess deaths were caused by the therapy."The potential of retinoid compounds to prevent cutaneous malignant lesions [skin cancers]...

2009-01-20 08:53:43

Patients who use creams with an ingredient commonly used to treat acne are more likely to die than those who don't, a new study reveals. The Veterans Affairs Topical Tretinoin Chemoprevention (VATTC) Trial began in 1998 to test whether high-dose therapy with a cream containing the retinoid tretinoin, could prevent cancer. 1,131 veterans, mostly men over age 70, were randomly assigned to apply either a cream containing 0.1 percent tretinoin or an unmedicated cream daily to their face and ears....

2009-01-06 08:30:00

Epiduo(TM) Gel Combines Retinoid and Benzoyl Peroxide in a Single Product; Performs Better than Either Component Alone FORT WORTH, Texas, Jan. 6 /PRNewswire/ -- Galderma Laboratories, L.P. today announced the availability of Epiduo(TM) (adapalene and benzoyl peroxide) Gel 0.1% / 2.5%, the first and only, once-daily, topical acne treatment that combines the well-tolerated retinoid adapalene, and benzoyl peroxide, a well-known antimicrobial with no evidence of promoting bacterial resistance....